Matches 1 - 50 out of 398 1 2 3 4 5 6 7 8 >
Match Document Document Title
7629367 N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators  
Compounds of structural formula I are modulators of the androgen receptor (AR) in a tissue selective manner. These compounds are useful in the enhancement of weakened muscle tone and the treatment...
7612236 Method for producing optically active bisamidoalcohol compound  
It is provided that a method for producing an optically active bisamidoalcohol compound represented by the formula (3): wherein R 1 represents a C1-6 alkyl group, an optionally substituted...
7601876 Compounds, compositions and methods for the treatment of amyloid diseases such as systemic AA amyloidosis  
Bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs and pharmaceutically acceptable esters, their synthesis, pharmaceutical compositions containing them, and their use in the...
7601872 Transfection reagents  
Disclosed are compounds capable of facilitating transport of biologically active agents or substances into cells having the general structure: wherein Q is selected from the group consisting...
7598412 Modulators of ATP-binding cassette transporters  
The present invention provides compounds of Formula I useful as modulators of ABC transporter activity, or a pharmaceutically acceptable salt thereof, wherein R B , n, B, R C , R D , R E , A,...
7547731 Formamide derivatives for the treatment of diseases  
The invention relates to compounds of formula (1) and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives....
7482487 Phenylaminoethanol derivatives as β2 receptor agonists  
The invention relates to compounds of formula (1) and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. The...
7479571 Generation of combinatorial synthetic libraries and screening for novel proadhesins and nonadhesins  
One aspect of the present invention relates to compounds, comprising at least two moieties selected from the group consisting of aryl sulfonates and aryl sulfates. A second aspect of the present...
7470817 Transfection reagents  
Disclosed are compounds capable of facilitating transport of biologically active agents or substances into cells having the general structure: wherein Q is selected from the group consisting...
7459585 Benzene derivatives and pharmaceutical use thereof  
The present invention provides an AP-1 activation inhibitor, NF-kappa B activation inhibitor, inflammatory cytokine production inhibitor, matrix metalloprotease production inhibitor, inflammatory...
7449493 Diamines as modulators of chemokine receptor activity  
The present application describes modulators of MCP-1 of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma, multiple sclerosis,...
7358383 Polyphenol proteasome inhibitors, synthesis, and methods of use  
The present invention relates to synthetic green tea derived polyphenolic compounds, their modes of syntheses, and their use in inhibiting proteasomal activity and in treating cancers. The present...
7351862 Alpha, omega-difunctional aldaramides  
Alpha, omega-difunctional aldaramides, in particular diaminoaldaramides, dihydroxyaldaramides, bis(alkoxycarbonylalkyl)aldaramides, and bis(carboxyalkyl)aldaramides, and processes for preparing the...
7348451 Additives for inhibiting gas hydrate formation  
The invention provides the use of compounds of the formula (1) where R 1 , R 2 are each independently C 1 - to C 22 -alkyl, C 2 - to C 22 -alkenyl, C 6 - to C 30 -aryl or C 7 - to C 30...
7238834 Piperidine derivatives and process for their production  
The present invention relates to substantially pure piperidine derivative compounds of the formulae: wherein R 1 is hydrogen or hydroxy; R 2 is hydrogen; or R 1 and R 2 taken...
7205437 Selective androgen receptor modulators  
The present invention relates to androgen receptor targeting agents (ARTA) which demonstrate androgenic and anabolic activity, which are nonsteroidal ligands for the androgen receptor. The...
7183431 Dihydroxy aromatic compounds and methods for preparation  
A dihydroxy aromatic compound having a Formula (I), wherein R 1 is a C 6 –C 60 aromatic divalent functionality, R 2 at each occurrence, can be the same or different and is independently at...
7129377 Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer  
The present invention relates to an androgen receptor alkylating compound, wherein the compound may include, inter alia, an active functional group, which permits the alkylation of the androgen...
7078565 Benzamide derivatives as antagonists of orexin receptors  
Disclosed are phenyl-alkylene benzamides useful as orexin antagonists
7053245 N-acylamino benzyl ether derivatives  
This invention relates to N-acylamino aryl derivatives of the formula where R 1 , R 21 , R 22 , R 23 , R 24 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R, and n are as defined herein and where X is...
7045660 Compounds as PDE IV and TNF-inhibitors  
This invention is directed to a [di(ether or thioether)heteroaryl or fluoro substituted aryl] compound or an N-oxide thereof or a pharmaceutically acceptable salt thereof, which is useful for...
7034015 Aminobenzoephenones  
The invention relates to a novel class of aminobenzophenones derivatives, to pharmaceutical preparations comprising said compounds, to dosage units of such preparations, to methods of treating...
7030201 Bottom antireflective coatings  
The present invention relates to bottom antireflective coating compositions and polymers useful in making such compositions.
6995285 ABCA-1 elevating compounds  
The present invention provides compounds that elevate cellular expression of the ABCA-1 gene, promoting cholesterol efflux from cells and increasing HDL levels in the plasma of a mammal, in...
6982348 Aminoethanol derivatives  
The present invention provides a pharmaceutical agent having cholesteryl ester transfer protein inhibitory action and useful as a blood lipid lowering agent and the like. The present invention...
6930203 Gelling agents or thickeners  
The present invention relates to a novel class of gelling agents or thickeners, to a process for preparing gelling agents or thickeners and to their use to prepare the gels. The present gelling...
6924392 Ortho, meta-substituted bisaryl compounds, processes for their preparation, their use as medicaments, and pharmaceutical preparations comprising them  
Ortho, meta-substituted bisaryl compounds, processes for their preparation, their use as medicaments, and pharmaceutical preparations including their use as antiarrhythmic active compounds, for...
6914160 Oxytocin inhibitors  
This invention relates to compounds of formula (I)
6903092 Naphthamide neurokinin antagonists for use as medicaments  
Compounds having the general formula wherein R 1 , R 2 , R 3 , R 4 , R 5 , X 1 and X 2 are as defined in the specification, methods of using such compounds for the treatment of diseases and...
6836383 Diphenylsquarylium compound and filter for display containing the same  
The object of the invention is to provide a diphenylsquarylium compound which has a sharp minimum value within the wavelength range of from 550 to 610 nm in the light transmittance curve and from...
6828458 Topical antiandrogen for hair loss and other hyperandrogenic conditions  
Compound (2-hydroxy-2-methyl-N-(4-X-3-(trifluoromethyl)phenyl)-3-(2,2 ,2-perfluoroacylamino)propionamide) applied topically, specifically inhibits and/or eliminates cutaneous androgen receptors and...
6821965 Amidobenzamide derivatives which are useful as cytokine inhibitors  
The invention concerns amide derivatives of the Formula (I) wherein R 3 is (1-6C)alkyl or halogeno; Q is aryl or heteroaryl which optionally bears 1, 2, 3 or 4 substituents such as hydroxy,...
RE38551 Anticonvulsant enantiomeric amino acid derivatives  
The present invention is directed to a compound in the R configuration about the asymmetric carbon in the following formula: pharmaceutical compositions containing same and the use thereof in...
RE38506 Potent inducers of terminal differentiation and methods of use thereof  
The present invention provides the compound having the structure: wherein each of R 1 and R 2 are independently the same as or different from each other; when R 1 and R 2 are the same, each...
6696472 Substituted N-phenoxy-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity  
The invention relates to substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamine compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma lipid transfer...
6677359 N-substituted glycine derivatives  
The present invention relates N-substituted glycine derivatives for treating or preventing neuronal damage associated with neurological diseases. The invention also provides compositions comprising...
6657083 5-acylamino-2-amino-4-substituted-phenol compounds and method of using them  
Disclosed is a 2-amino-5-acylamino-4-substituted-phenol compound having the structural formula I: wherein Y is a substituent group, and R′ is a ballast group. Also disclosed is a simplified...
6635786 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (ADP-ribose) glycohydrolase, and methods for their use  
Symmetrically disubstituted aromatic compounds and pharmaceutical compositions containing such compounds that inhibit and/or modulate the activity of poly(ADP-ribose) glycohydrolase, also known as...
6632836 Carbocyclic potassium channel inhibitors  
The present invention relates to a class of carbocyclic compounds of Formula I that are useful as potassium channel inhibitors to treat autoimmune disorders, cardiac arrhythmias, and the like.
6576642 Diamide compounds and compositions containing the same  
Compounds having the formula (1): wherein A is a phenyl, naphthyl, dihydronaphthyindeny, pyridyl, indolyl,isoindolyl, quinolyl or isoquinolyl group which are optionally substituted; X is...
6563002 Biscyclopropanecarboxamide compounds and pharmaceutical use thereof  
The present invention discloses biscyclopropanecarboxamide compounds and pharmaceutically acceptable salts thereof; and also NF-kappa B activation inhibitors, Inflammatory cytokine production...
6562963 Process for the preparation of macrocyclic metalloprotease inhibitors  
The present invention is directed to a process for the preparation of a compound of formula (X-a) or a pharmaceutically acceptable salt form thereof, wherein: R 1 is selected from the group...
6548703 Toning agent  
A toning agent for an azo pigment, an azo pigment with a modified tone, and process for preparing the same are provide. 2-hydroxynaphthalene-3,6-dicarboxylic acid or a derivative thereof is admixed...
6528655 Aromatic derivatives with HIV integrase inhibitory properties  
A compound of formula I′ and pharmaceutically acceptable derivatives thereof including, for example, where applicable or appropriate pharmaceutically acceptable salts thereof. Ar and Ar′ are...
6525219 4-amino-2-hydroxy-5-substituted-acylanilide compounds and method of using them  
Disclosed is a 4-amino-2-hydroxy-5-substituted-acylanilide compound having the structural formula I: wherein R is hydrogen or an alkyl group, and Y is a substituent group linked to the rest of...
6521607 (R)-chiral halogenated substituted N-phenoxy N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity  
The invention relates to substituted aryl and heteroaryl (R)-Chiral Halogenated 1-Substitutedamino-(n+1)-Alkanol compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma...
6492553 Methods for preparing N-&lsqb (aliphatic or aromatic)carbonyl)&rsqb -2-aminoaetamide compounds and for cyclizing such compounds  
A method for preparing a N-[(aliphatic or aromatic)carbonyl)]-2-aminoacetamide compound, and for preparing a cyclized compound therefrom, as well as novel resin bound intermediate compounds that...
6489364 Antiviral protease inhibitors  
Compounds of formula (I), wherein A′ and A″ are independently the same or different group of formula (II) wherein: R′ is H, CH 3 , C(CH 3 ) 2 , —OR a , —N(R a ) 2 , —N(R a )OR a or...
6444849 Amide derivatives  
A compound represented by the following general formula (1); wherein X represents R 1 (R 2 )(R 3 )C— where R 1 represents a C 3 -C 8 cycloalkyl group, an optionally substituted C 6 -C 14 ...
6420427 Aminobutyric acid derivatives  
An aminobutyric acid derivative of the formula (I): (wherein all symbols are as defined in the specification) and salt thereof. salt thereof. The compounds of the formula (I) possess an...
Matches 1 - 50 out of 398 1 2 3 4 5 6 7 8 >